Laparoscopy: Main Manufacturers in the world
- The new coronavirus may kill cancer cells and achieve a permanent cure!
- Why did the Alzheimer’s drug candidate BACE1 inhibitor fail?
- LRTI Death: Research spanning 80 years confirms for the first time
- The decline of the global antibiotic market is threatening the development of new drugs
- World first: An mRNA vaccine that can 100% protect against deadly bacterial infections is available
- The first successful use of CAR-T cells to treat severe muscle inflammation
Laparoscopy: Main Manufacturers in the world
Laparoscopy: Main Manufacturers in the world. Analysis of Laparoscopy manufacturers including Industry-Braun, Boston Scientific, Kangmei, Johnson & Johnson, Karl Storz and Chinese manufacturers.
Laparoscope, similar to gastroscope and colonoscope, is a medical device with a light source and a miniature camera, and belongs to Class III medical device. The complete set of equipment includes laparoscopy, energy system, light source system, perfusion system, imaging system and commonly used laparoscopic surgical instruments (such as puncture needles, trocars, separation forceps, coagulation hooks and coagulation rods, clip appliers, titanium Clips, scissors, needle holders, snares, etc.) are mainly used in general surgery, gynecological surgery and other surgical operations. In the laparoscopic surgery industry, there are also many disruptive innovative products, such as 3D laparoscopy.
In laparoscopic surgery, the doctor sends the laparoscope into the abdominal cavity through a small wound in the patient’s abdomen, and the laparoscopic camera can return the condition of the patient’s abdominal cavity to the monitor of the video surveillance system for doctors to check and operate. Compared with traditional open surgery, laparoscopic surgery has the advantages of less trauma, light postoperative pain, quick recovery, and beautiful appearance. It is a key technology to realize minimally invasive diagnosis and treatment.
Industry competitive landscape
The medical device market is one of the fastest growing and most active international trade markets in the global economy, and the laparoscopy market is the fastest growing category in the global medical device market. The advancement of science and technology and the growth of minimally invasive technology applications will continue to promote the rapid expansion of the laparoscopy market.
According to the “Global Laparoscopy Devices Market Opportunity and Forecast, 2020-2027” report released by Allied Market Research in April 2020, the laparoscopic device market will grow at a compound annual growth rate of 5.8%. By 2027, the global laparoscopic device market The scale will grow from US$12 billion in 2019 to US$18.9 billion.
North America and Europe are the two major consumer markets for laparoscopic equipment in the world. In 2019, North America is the main source of income for the global laparoscopic equipment market, mainly due to the increasing elderly population in the region and the prevalence of gastrointestinal and abdominal diseases in the region. Europe has the second largest share of the global laparoscopic equipment market. For the Asia-Pacific region where the current laparoscopic market share is relatively small, the huge population base, the increasing affordability of patients and the improvement of healthcare facilities will drive the laparoscopic equipment market growth of.
Major global supplier of laparoscopy
The laparoscopic equipment industry is highly concentrated. The manufacturers with the largest share of the laparoscopy market in the world include: B. Braun, Boston Scientific Corporation, ConMed Corporation, Johnson & Johnson, Karl Storz SE & CO. KG, Karl Storz.
1. B. Braun, Braun Medical
Braun Medical is a German medical and pharmaceutical equipment company founded in 1839 and its headquarters is located in Melsungen, central Germany. Braun Medical has more than 5,000 different healthcare products. The company’s revenue in 2018 was 6.908 billion euros.
As a subsidiary of Braun Medical, Aesculap was established in Tuttlingen, Germany in 1867, and established an American branch in the Central Valley of Pennsylvania in 1977. It produces a series of equipment, including sutures, hand-held surgical instruments, implants, and electrosurgical equipment and power systems. It also provides training for medical staff through its Aesculap Academy.
On November 7th this year, the third CIIE will be held in Shanghai. Braun Medical Asia first released a new generation of 3D laparoscopic system. The equipment is equipped with the industry’s largest optical CMOS chip, and is the first to use NAJA disposable sterile, making it possible to operate on one stage.
2. Boston Scientific Corporation, Boston Scientific
Boston Scientific was established in Watertown, Massachusetts on June 29, 1979. It is a manufacturer of interventional medical equipment, including interventional radiology, interventional cardiology, peripheral intervention, neuromodulation, neurovascular intervention, and electrical Physiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology, and gynecology. Boston Scientific’s total revenue in 2019 reached 10.7 billion US dollars, of which endoscopy revenue was 1.9 billion US dollars, accounting for 17.8%.
3. ConMed Corporation, Kangmei
Kangmei’s history began in 1970 as a combined medical device company founded by Eugene Kolasanti in Utica, New York. Kangmei produces and sells thousands of products to suppliers in the healthcare industry, and is in a leading position in the orthopedics, general surgery, gynecology, gastrointestinal, laparoscopy, cardiology and critical care markets.
SurgiQuest was established in Connecticut in 2006 and was acquired by CONMED in 2016. The company is mainly engaged in the design and development of laparoscopic sleeves, and strives to eliminate the troubles caused by traditional sleeves such as round seals and duckbill valves since the early 1990s. After the establishment of the company, the AirSeal, a non-cannulated inflation circulatory system, was launched, which is the world’s first and only non-cannulated circulatory system connected to laparoscopic and robotic surgery.
Since SurgiQuest joined CONMED, CONMED has achieved rapid sales growth. In 2016, CONMED’s fiscal year sales exceeded 760 million US dollars, setting a sales record for CONMED.
4. Johnson & Johnson, Johnson & Johnson
Johnson & Johnson is an American multinational company founded in 1886, mainly developing medical devices, medicines and consumer packaged goods. Ranked 37th in total income in the Fortune 500 in 2018. Johnson & Johnson is one of the most valuable companies in the world.
Ethicon is a subsidiary of Johnson & Johnson. Prior to 1992, Ethicon Endoscopic Surgery was a part of Ethicon, and later became an independent corporate entity under Johnson & Johnson to expand and diversify Johnson & Johnson’s product line. As a subsidiary of Johnson & Johnson, Ethicon Endoscopic Surgery manufactures surgical equipment and equipment for open surgery and minimally invasive surgery in the fields of obesity, gastrointestinal health, gynecology and tumor surgery. Its products include endoscopes and laparoscopic tools.
5. Karl Storz SE & CO. KG Karl Storz
Since its establishment in 1945, the Karl Storz family company has grown into a global manufacturer and distributor of endoscopes, medical devices and equipment. Endoscope instruments range from human medicine, veterinary medicine to industrial endoscopes, including more than 15,000 products. The company’s most recent development centers are digital file systems and integrated operating rooms. As a system supplier, the company combines its endoscopy expertise with software solutions to achieve the integration of the operating room and support the clinical process and resource management.
The biggest laparoscopy market: China
China’s medical device market is large and fast-growing. The size of China’s medical device market has increased from RMB 312.6 billion in 2015 to RMB 664.2 billion ( about US Dollar 103 billion) in 2019, with a compound annual growth rate of 20.7%. It is expected that, driven by the aging population, the rising incidence of chronic diseases, the continuous increase in the number of hospitals and doctors and the increase in affordability, as well as the favorable government policies, China’s medical device market will reach 1.391.9 billion yuan in 2024. The compound growth rate will be 15.9%.
In fact, China’s market for minimally invasive surgical instruments and accessories (MISIA) is also developing rapidly. The scale of China’s MISIA market increased from 9.6 billion yuan in 2015 to 18.5 billion yuan in 2019, with a compound annual growth rate of 17.8%. It is estimated that the compound annual growth rate from 2019 will be 17.2%, and the market size will reach 40.8 billion yuan.
Chinese laparoscopic manufacturers:
Kangji Medical is currently the largest minimally invasive surgical instrument and accessories (MISIA) platform in China. The company was founded in August 2004 by Mr. Zhong Ming and Ms. Shentu. It has a comprehensive product portfolio covering major minimally invasive surgery in order to provide doctors and hospitals with one-stop and tailor-made surgical solutions. Its main products include disposable cannula puncture, polymer ligation clamp, disposable electrocoagulation forceps, etc. In 2019, the company’s MISIA market share was 2.7%, ranking first among Chines manufacturers.
Main laparoscopic manufacturers in China :
- Kangji Medical
- Zhejiang Tiansong Medical Equipment,
- Jiangsu Yuyue Medical Equipment,
- Shenyang Shenda Endoscope,
- Chengdu Xinxing Endoscope.
Although, with the development of minimally invasive techniques in clinical medicine, the market demand for laparoscopy in China is growing rapidly, but more than 3/4 of the market is monopolized by foreign brands, and Chinese brands have less than a quarter of the market.
However, laparoscopy in some developing countries like Southeast Asia and South America, is in the emerging stage. It is more price-sensitive and requires relatively low product performance. Some Chinese companies are targeting overseas markets for sales and opening up increments.
Causes of the existing pattern
The first reason-high technical barriers in the industry:
Laparoscopy is a device integrating optics, electronics, structure, materials and other multi-disciplinary technologies, and has extremely high technical barriers. The mirror body contains multiple channels, including illumination fibers, image transmission fibers, air transmission channels, water transmission channels, etc., requiring the cooperation of talents in multiple professional fields.
The core components are the lens and image sensor, and the technical difficulty is the design of the camera optical module.
Image processing algorithms and imaging:
noise reduction technology and edge enhancement technology, such as NBI narrowband imaging technology and FICE spectroscopy technology, and Japanese manufacturers have applied for many patents for protection.
Materials and processing technology:
There are a large number of patents and technical know-how in terms of microstructure and materials. For example, find materials of moderate hardness suitable for insertion, and mass-produce ultra-fine part processing and assembly processes.
The second major reason-the first-mover advantage is obvious, established companies have established industrial moats:
Upstream technology blockade:
block the export of upstream core components, plan ahead for patent blockade, and overseas companies do not set up R&D centers in China to prevent the loss of talents and technology.
While mass production, it ensures product qualification rate and quality stability, while reducing consumption and cost, and establishing a manufacturing management system for excellence.
Market promotion and doctor education:
Many doctors in the top three hospitals have been trained by Olympus, formed specific operating habits, and have more trust and reliance on Japanese brands.
The establishment and improvement of the supply chain:
The selection and cooperation of suppliers worldwide, the bargaining power of upstream and downstream.
In recent years, the “surgical procedure” segment represented by minimally invasive surgery will continue to become a growth hotspot and will be an important direction for future medical development. Many disruptive innovative products, such as 3D laparoscopy, are also emerging in the laparoscopic surgery industry. At present, the Chinese domestic rigid endoscope industry in China is on the rise. Compared with the general imported rigid endoscope and its supporting equipment, there are no major technical problems and there is a price advantage.
(source:chinanet, reference only)
Disclaimer of medicaltrend.org